Navigation Links
Smart Balance Announces 2009 Second Quarter Results
Date:8/6/2009

( )

PARAMUS, N.J., Aug. 6 /PRNewswire-FirstCall/ -- Smart Balance, Inc. (Nasdaq: SMBL) today announced its results for the second quarter ended June 30, 2009. The Company reported net sales of $58.2 million, an increase of 21.2% versus year ago, and earnings per share of $0.02, versus a loss of $0.02 per share in 2008.

The second quarter net sales increase versus 2008 was due to a 13% volume growth in case shipments and higher pricing carried over from the prior year. The improvement in earnings per share was due to increased gross profits and lower financing-related costs, partially offset by higher operating expenses.

The Company increased market share in its core category of spreads by 1.2 points to 14.8% in the second quarter versus the same quarter in 2008, representing the 30(th) consecutive quarter of market share growth, according to Information Resources, Inc. (IRI) data.

"In a quarter where competitive intensity increased, I am pleased with our continued share growth in our core category of spreads," said Stephen B. Hughes, Smart Balance Chairman and CEO. "Consumers have learned that Smart Balance is the company to trust to always deliver the heart healthiest, best tasting spread in the market place."

Gross profit margin for the quarter improved to 48.6% versus 41.4% for the second quarter of 2008, due to lower commodity costs and higher pricing carried over from 2008, partially offset by higher promotion expenses.

The Company paid down debt by $5.0 million during the quarter, bringing total long-term debt to $64.5 million. The Company has reduced debt by $95.5 million, or 60%, since the acquisition of GFA Brands in May, 2007, and expects to continue to pay down
'/>"/>

SOURCE Smart Balance, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine news :

1. Smart Choices Program helps shoppers identify food and beverage choices
2. Innovation to Unveil Next Generation of PharmASSIST SmartCabinet at NACDS Pharmacy & Technology Conference
3. Crisco(R) Announces the Crisco Live Smart, Cook Smarter Contest Winners
4. Smart for Life(TM) and THINADVENTURE(TM) Sponsor Brandon Flowers Youth Sports Camp
5. Smart Ideas at the Intersection of Transportation, Health, and Equity
6. Netsmart Technologies Acquires Pharmacy Management Software Company
7. Smart for Life(TM) Featured in Womans World Magazine
8. Smart Balance to Host Webcast/Conference Call on 2009 Second-Quarter Results
9. Netsmart Technologies Ranked in Healthcare Informatics Top 100
10. Smart for Life(TM) Introduces HeroFiber(TM) to Its Product Line
11. On Memory, Older Americans Outsmart the English
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:FDA Makes Interim Recommendations to Address Concern of Excess Radiation Exposure during CT Perfusion Imaging 2FDA Makes Interim Recommendations to Address Concern of Excess Radiation Exposure during CT Perfusion Imaging 3Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 2Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 3Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 4Octapharma USA Announces FDA Approval of wilate(R) - the First Replacement Therapy Developed Specifically for von Willebrand Disease 5Stallergenes: Oralair: Very Positive 3-Year Results of the Long-Term Study 2Stallergenes: Oralair: Very Positive 3-Year Results of the Long-Term Study 3Stallergenes: Oralair: Very Positive 3-Year Results of the Long-Term Study 4Stallergenes: Oralair: Very Positive 3-Year Results of the Long-Term Study 5Nonprofit Goes RVing to Promote Pet and Human Health 48962 1Nonprofit Goes RVing to Promote Pet and Human Health 48962 2Nonprofit Goes RVing to Promote Pet and Human Health 48962 3HPV Vaccine Acceptability Study Announces Results 48959 1HPV Vaccine Acceptability Study Announces Results 48959 2HPV Vaccine Acceptability Study Announces Results 48959 3Heart Association Warns of Surgery Risks in Obese 48956 1Heart Association Warns of Surgery Risks in Obese 48956 2